Loren Data's SAM Daily™

fbodaily.com
Home Today's SAM Search Archives Numbered Notes CBD Archives Subscribe
FBO DAILY ISSUE OF AUGUST 12, 2010 FBO #3183
MODIFICATION

A -- Production of Master Seeds and Pre-Licensing Serials for Foreign Animal Disease Vaccine Candidates

Notice Date
8/10/2010
 
Notice Type
Modification/Amendment
 
NAICS
541711 — Research and Development in Biotechnology
 
Contracting Office
Office of the Chief Procurement Officer, Washington, District of Columbia, 20528, United States
 
ZIP Code
20528
 
Solicitation Number
HSHQDC-10-R-00054
 
Response Due
8/20/2010 4:00:00 PM
 
Archive Date
9/4/2010
 
Point of Contact
Kristian Jovanovic, Phone: 202-254-6071
 
E-Mail Address
Kristian.Jovanovic@dhs.gov
(Kristian.Jovanovic@dhs.gov)
 
Small Business Set-Aside
N/A
 
Description
Solicitation amendment to reflect additional Government answers to industry questions. All other terms and conditions of RFP shall remain unchanged, including due date. 1. What role does DHS play in the development of countermeasures for foreign animal diseases in the U.S.? ANSWER: HSPD-9 tasks DHS to coordinate with USDA, HHS and other agencies, in consultation with the Office of Science and Technology Policy, in accelerating and expanding the development of current and new countermeasures against the intentional introduction or natural occurrence of catastrophic animal, plant, and Zoonotic diseases. The capability requirements identified in HSPD-9 are also reflected in the National Response Framework (NRF), particularly as part of Emergency Support Function 11 (ESF-11), in addressing the protection of agriculture as part of the NRF. 2. How does DHS carry out its mission to accelerate and expand the development of countermeasures for catastrophic animal diseases? ANSWER: DHS coordinates with intra- and inter-agency stakeholders through two main pathways. First, in response to the task in HSPD-9, DHS co-chairs the National Science and Technology Council's Foreign Animal Disease Threat (FADT) Subcommittee with USDA's Agricultural Research Service. Other members of the subcommittee include USDA APHIS, HHS, DOD, EPA, NSF, DOI, and the Smithsonian Institution. The FADT Subcommittee coordinates interagency research programs in veterinary countermeasures; modeling; decontamination, disposal and depopulation; and basic research. In addition DHS's Science and Technology (S&T) Directorate has formed a FAD Vaccines and Diagnostics Project IPT to review critical research gaps identified by stakeholders, the progress made by (or known to) all participating agencies to date, and develop a plan to address the highest priority gaps through interagency partnerships. The Project IPT will provide an enduring capability for the advanced development of FAD countermeasures by employing a gated decision-making process with clearly defined transition endpoints for individual products. DHS S&T's Targeted Advanced Development (TAD) Program, housed at the Plum Island Animal Disease Center, implements the recommendations of the FADT and the Project IPT through strategic investments in the advanced development of new and novel technologies. As there is little to no commercial market in the United States for vaccines and diagnostics for FAD pathogens, the objective of the TAD program is to advance the technology to a point attractive to industry investment. To this end, DHS strongly supports industry partner involvement in the development, licensure and production process. Having an industry partner assume responsibility for product licensing and manufacturing ensures that DHS fulfills its mission to transition projects to industry in order to achieve the technology readiness level required for field deployment during an emergency response. DHS seeks industry partners interested in developing international markets for FAD vaccines and diagnostics licensed and produced domestically. This is based on a strategic plan to have a commercial manufacturer, preferably in the U.S., who will export vaccines to endemic markets. This would help ensure that the U.S. manufacturer has sufficient inventory and capacity available domestically that might be used in response to an accidental or intentional FAD outbreak within the U.S. While DHS recognizes the value of having readily available supplies of vaccines available in the event of an outbreak in the U.S., any and all decisions related to the response to an FAD outbreak in the U.S., including whether or not to vaccinate and which product might be used, are made by the United States Department of Agriculture.
 
Web Link
FBO.gov Permalink
(https://www.fbo.gov/spg/DHS/OCPO/DHS-OCPO/HSHQDC-10-R-00054/listing.html)
 
Place of Performance
Address: Plum Island Animal Disease Center, Greenport, New York, 11944, United States
Zip Code: 11944
 
Record
SN02234986-W 20100812/100810235425-7f76cecc43b0092435a5f91d602b79ef (fbodaily.com)
 
Source
FedBizOpps Link to This Notice
(may not be valid after Archive Date)

FSG Index  |  This Issue's Index  |  Today's FBO Daily Index Page |
ECGrid: EDI VAN Interconnect ECGridOS: EDI Web Services Interconnect API Government Data Publications CBDDisk Subscribers
 Privacy Policy  Jenny in Wanderland!  © 1994-2024, Loren Data Corp.